BY UE STUDIO
Updated Friday, February 2, 2024-12:29
Share on Facebook
Share on X-Twitter
Send by email
La Roche-Posay, the dermocosmetic brand most recommended by dermatologists worldwide, has the mission of developing the most effective and highest-tolerance care for the most sensitive skin. Within this mission is also the
commitment to accompany cancer patients
with products to try to improve the adverse effects that occur on the skin due to oncological treatments, in addition to increasing their daily comfort and quality of life.
The brand was born in the thermal center of La Roche-Posay, founded in 1905,
thanks to a
thermal water very rich in selenium
that has been shown to have healing properties for different skin conditions such as atopic dermatitis, psoriasis, burn patients, etc. .
In 2008, the thermal center began to provide specific care for
the side effects on the skin of patients undergoing oncological therapies such as chemotherapy and radiotherapy
, among others. In fact, French social security covers comprehensive hydrothermal treatment for patients throughout the country if doctors consider it appropriate to prescribe a stay at the center. The experience accumulated over the years has helped La Roche Posay to specialize in this area, to which it has dedicated numerous resources to validate the safety of the products with clinical studies and
boards
of national and international experts. The objective is to improve the quality of life of these patients, both in France and in the other sixty countries in which it is present.
A clear example of this commitment to cancer patients is the creation of the so-called
Skin Care Units
present in 44 public and private hospitals in Spain. As a result of collaboration work with different hospitals, these spaces have been created where the patient receives optimal guidance and appropriate dermocosmetic advice on basic skin care, before, during and after treatments with the most
appropriate
products
that comply with with a very strict formulation letter that ensures their tolerance, safety and effectiveness.
La Roche-Posay products are characterized by
a very strict formulation that guarantees their effectiveness and maximum skin tolerance, always with proven scientific evidence and severe dermatological tests.
In those products that are aimed not only at sensitive skin but also at cancer patients, the formulations have undergone tests on patients who are in this process with the supervision of scientists and healthcare professionals.
La Roche-Posay has 5 ranges for the needs of these patients
. For
hygiene
, both head, face and body have
Lipikar Syndet AP+.
They also have
moisturizing face and body care products that restore the skin's skin barrier
, such as
Lipikar Baume AP+M
for the body and
Toleriane Dermoallergo
for the face
.
It also has
epidermal repairers
that help in processes that cause fissures, erosions, eczema and wounds,
such as Cicaplast Baume B5+
.
Very broad spectrum UVB-UVA photoprotection
is
essential to prevent photosensitivity and, for this purpose,
Anthelios UVMUNE 400
has been developed . Finally,
the range of corrective makeup
that improves the physical and psychological impact of oncological treatments, which contributes to recovering the patient's quality of life during the healing process.
La Roche-Posay is present in 44 skin units of public and private hospitals in Spain.
Currently,
La Roche-Posay is present with 44 skin units in public and private hospitals in Spain
. In them, the patient has training and information on dermocosmetic care and can learn to use corrective makeup to mask the most visible signs of the disease and, thus, strengthen its image.
Training is another of the pillars of La Roche-Posay
. For this reason, it works together with hospitals to promote dermocosmetic care through clinical sessions carried out by the brand's qualified personnel to different specialists. And, aware of
the importance of the pharmacist
in this process, they also created a specific training course six years ago that more than 13,000 professionals have gone through. This activity is in addition to collaborations with scientific societies such as the Piel Sana foundation of the Spanish Academy of Dermatology, the Spanish Society of Oncological Nursing (SEEO) or the Spanish Society of Radiation Oncology (SEOR). Currently, he participates
in a first study on the reduction of side effects on the skin due to immunotherapy treatments at the Sant Pau Hospital in Barcelona.
In collaboration with a group of experts made up of dermatologists, oncologists, radiation oncologists and pharmacists,
La Roche-Posay has identified a total of 23 side effects derived from the different therapies
. Among them is
xerosis or dry skin
; erythema (redness and burning sensation), acne-like eruptions or very intense itching, to name a few. These are some of the consequences that appear during this process, which transforms those who go through it. La Roche-Posay professionals defend the value of dermocosmetics not only to repair the skin, but because it
helps patients with the image returned in the mirror.
A powerful ally to complete this path.
Made by UE Studio
This text has been developed by UE Studio, creative branded content and content marketing firm of Unidad Editorial, for LA ROCHE-POSAY